January 2019, ISSUE 123
Dear DiabetesSister,

We've wasted no time starting 2019 with a bang - already we have programs planned, welcoming the year with open arms. I hope you, too, are ready to face the new year. Let's do it together - happy new year!

In Sisterhood,
Anna
Anna Norton, MS, CEO
25 Triumphant (NOT Perfect!) Years THRIVING with Diabetes
2018 was another big year for DiabetesSisters. We continued to grow our current programs and content, and introduced several new initiatives as well. We are recapping the highlights in our 2018 Year in Review infographic!

DiabetesSisters is a 501(c)(3) nonprofit organization whose mission is to improve the health and quality of life of women with diabetes, and to advocate on their behalf. We believe all women with diabetes should have access to a healthy support system that includes peers with diabetes. 

We are thrilled to introduce Between the Lines, a new series featuring stories of real women living real lives while having diabetes. This month we explain how Between the Lines came to be, and Tricia discusses navigating health insurance and job options. 

In business, CEOs work with experts and surround themselves with a strong team. As a patient, do you do this for your health? Learn how to be the CEO of Your Health with this guide full of resources. Part of our #AcessMatters series.

Check out the latest articles from our experts!


Ask our RD: 17 Years Ago

We are braving the cold winter weather of Minnesota for this month's PODS Spotlight. Bundle up and visit our Minneapolis/St. Paul PODS Meetup group to learn how leading a PODS Meetup has offered Rachel an opportunity to socialize and get to know the local geography after moving to the Twin Cities area.

What are the top things that women with diabetes need to know about cardiovascular disease? Our Heart Health brochure has the answers. It is available for download, in English and Spanish, in our Educational Library.

Participate in an upcoming Type 2 Diabetes Usability Study! Qualifying participants can earn $75 or more by giving user feedback on prototypes in development.

Please mention at the end of the form that you were referred from DiabetesSisters.

We are proud to partner with several diabetes organizations to learn more about the experiences of people with type 1 who are taking SGLT-2 inhibitors. Your perspective may be shared with the FDA to inform their decisions on this therapeutic class (no personal identifying information will be shared).

Chattanooga, TN
January 3, 6:30pm

Richmond, VA
(West End)
January 6, 1:00pm

Rochester, NY (Westside)
January 7, 6:00pm

St. Augustine, FL
January 7, 6:00pm

Ventura County/West San Fernando Valley, CA
January 7, 6:30pm

Portland, OR
January 7, 6:45pm

Jacksonville, FL
January 9, 7:00pm
Princeton, NJ
January 9, 7:00pm

Durham, NC
January 10, 5:30pm

Clifton Park, NY
January 12, 10:00am

Austin, TX
January 12, 10:00am

Minneapolis/St Paul, MN
January 12, 10:30am

Columbus, OH
January 12, 12:00pm

Reno, NV
January 15, 6:30pm
Chesapeake, VA
January 17, 6:30pm

Richmond, VA (Chesterfield)
January 17, 7:00pm

Virtual / Online
January 17, 8:00pm EST

Albany/Schenectady, NY
January 22, 6:15pm

Rochester, NY (CollegeTown/U of R)
January 22, 6:30pm

Bridgewater, NJ
January 23, 7:00pm

Denver, CO
January 27, 3:00pm